199 related articles for article (PubMed ID: 11278511)
1. Structure of human thymidylate synthase suggests advantages of chemotherapy with noncompetitive inhibitors.
Phan J; Steadman DJ; Koli S; Ding WC; Minor W; Dunlap RB; Berger SH; Lebioda L
J Biol Chem; 2001 Apr; 276(17):14170-7. PubMed ID: 11278511
[TBL] [Abstract][Full Text] [Related]
2. Effects of ligand binding and conformational switching on intracellular stability of human thymidylate synthase.
Berger SH; Berger FG; Lebioda L
Biochim Biophys Acta; 2004 Jan; 1696(1):15-22. PubMed ID: 14726200
[TBL] [Abstract][Full Text] [Related]
3. Structural analyses of human thymidylate synthase reveal a site that may control conformational switching between active and inactive states.
Chen D; Jansson A; Sim D; Larsson A; Nordlund P
J Biol Chem; 2017 Aug; 292(32):13449-13458. PubMed ID: 28634233
[TBL] [Abstract][Full Text] [Related]
4. The complex of the anti-cancer therapeutic, BW1843U89, with thymidylate synthase at 2.0 A resolution: implications for a new mode of inhibition.
Stout TJ; Stroud RM
Structure; 1996 Jan; 4(1):67-77. PubMed ID: 8805515
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of a deletion mutant of human thymidylate synthase Delta (7-29) and its ternary complex with Tomudex and dUMP.
Almog R; Waddling CA; Maley F; Maley GF; Van Roey P
Protein Sci; 2001 May; 10(5):988-96. PubMed ID: 11316879
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the active form of native human thymidylate synthase in the absence of bound substrates.
Deschamps P; Réty S; Bareille J; Leulliot N
Acta Crystallogr F Struct Biol Commun; 2017 Jun; 73(Pt 6):336-341. PubMed ID: 28580921
[TBL] [Abstract][Full Text] [Related]
7. Kinetic scheme for thymidylate synthase from Escherichia coli: determination from measurements of ligand binding, primary and secondary isotope effects, and pre-steady-state catalysis.
Spencer HT; Villafranca JE; Appleman JR
Biochemistry; 1997 Apr; 36(14):4212-22. PubMed ID: 9100016
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of thymidylate synthase mutant R166Q: structural basis for the nearly complete loss of catalytic activity.
Sotelo-Mundo RR; Changchien L; Maley F; Montfort WR
J Biochem Mol Toxicol; 2006; 20(2):88-92. PubMed ID: 16615077
[TBL] [Abstract][Full Text] [Related]
9. Refined structures of substrate-bound and phosphate-bound thymidylate synthase from Lactobacillus casei.
Finer-Moore J; Fauman EB; Foster PG; Perry KM; Santi DV; Stroud RM
J Mol Biol; 1993 Aug; 232(4):1101-16. PubMed ID: 8371269
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of human thymidylate synthase: a structural mechanism for guiding substrates into the active site.
Schiffer CA; Clifton IJ; Davisson VJ; Santi DV; Stroud RM
Biochemistry; 1995 Dec; 34(50):16279-87. PubMed ID: 8845352
[TBL] [Abstract][Full Text] [Related]
11. Partitioning roles of side chains in affinity, orientation, and catalysis with structures for mutant complexes: asparagine-229 in thymidylate synthase.
Finer-Moore JS; Liu L; Schafmeister CE; Birdsall DL; Mau T; Santi DV; Stroud RM
Biochemistry; 1996 Apr; 35(16):5125-36. PubMed ID: 8611496
[TBL] [Abstract][Full Text] [Related]
12. Human thymidylate synthase is in the closed conformation when complexed with dUMP and raltitrexed, an antifolate drug.
Phan J; Koli S; Minor W; Dunlap RB; Berger SH; Lebioda L
Biochemistry; 2001 Feb; 40(7):1897-902. PubMed ID: 11329255
[TBL] [Abstract][Full Text] [Related]
13. Substitution at residue 214 of human thymidylate synthase alters nucleotide binding and isomerization of ligand-protein complexes.
Steadman DJ; Spencer HT; Dunlap RB; Berger SH
Biochemistry; 1999 Apr; 38(17):5582-7. PubMed ID: 10220346
[TBL] [Abstract][Full Text] [Related]
14. Human thymidylate synthase with loop 181-197 stabilized in an inactive conformation: ligand interactions, phosphorylation, and inhibition profiles.
Luo B; Repalli J; Yousef AM; Johnson SR; Lebioda L; Berger SH
Protein Sci; 2011 Jan; 20(1):87-94. PubMed ID: 21064161
[TBL] [Abstract][Full Text] [Related]
15. Catalytic cysteine of thymidylate synthase is activated upon substrate binding.
Phan J; Mahdavian E; Nivens MC; Minor W; Berger S; Spencer HT; Dunlap RB; Lebioda L
Biochemistry; 2000 Jun; 39(23):6969-78. PubMed ID: 10841779
[TBL] [Abstract][Full Text] [Related]
16. Structures of human thymidylate synthase R163K with dUMP, FdUMP and glutathione show asymmetric ligand binding.
Gibson LM; Celeste LR; Lovelace LL; Lebioda L
Acta Crystallogr D Biol Crystallogr; 2011 Jan; 67(Pt 1):60-6. PubMed ID: 21206062
[TBL] [Abstract][Full Text] [Related]
17. The catalytic mechanism and structure of thymidylate synthase.
Carreras CW; Santi DV
Annu Rev Biochem; 1995; 64():721-62. PubMed ID: 7574499
[TBL] [Abstract][Full Text] [Related]
18. The crystal structure of thymidylate synthase from Pneumocystis carinii reveals a fungal insert important for drug design.
Anderson AC; Perry KM; Freymann DM; Stroud RM
J Mol Biol; 2000 Mar; 297(3):645-57. PubMed ID: 10731418
[TBL] [Abstract][Full Text] [Related]
19. The role of protein dynamics in thymidylate synthase catalysis: variants of conserved 2'-deoxyuridine 5'-monophosphate (dUMP)-binding Tyr-261.
Newby Z; Lee TT; Morse RJ; Liu Y; Liu L; Venkatraman P; Santi DV; Finer-Moore JS; Stroud RM
Biochemistry; 2006 Jun; 45(24):7415-28. PubMed ID: 16768437
[TBL] [Abstract][Full Text] [Related]
20. The structure of Cryptococcus neoformans thymidylate synthase suggests strategies for using target dynamics for species-specific inhibition.
Finer-Moore JS; Anderson AC; O'Neil RH; Costi MP; Ferrari S; Krucinski J; Stroud RM
Acta Crystallogr D Biol Crystallogr; 2005 Oct; 61(Pt 10):1320-34. PubMed ID: 16204883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
